JUST IN　•　MarketWatch.com - Top Stories

Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock is rallying.

SHARE THIS STORYPLUS UNLOCKS FAVORITES READ LATER AND SOURCE CONTROL

The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.

READ ORIGINAL REPORT ↗

THIS JUST HAPPENED PACKAGES THE WORLD INTO A FAST LIVE FEED SOURCE REPORTING STAYS ONE CLICK AWAY

RELATED POSTSMORE FINANCE

FINANCE　•　Variety

Juliana Stock Exiting as A+E’s Marketing and Digital Chief to Become Hearst Magazines President

FINANCE　•　MarketWatch.com - Top Stories

Caterpillar’s stock is sinking. Here’s what that means for the Dow.

FINANCE　•　CBC | Top Stories News

‘Crypto King’ Aiden Pleterski found guilty of fraud at his jury trial in Toronto

FINANCE　•　news – ZDNET

Stop sharing your passwords with AI agents, Bank of America warns customers

FINANCE　•　CBC | Top Stories News

What the jury didn't hear at 'Crypto King' Aiden Pleterski’s fraud trial

FINANCE　•　CBC | Top Stories News

Financial intelligence agency slow to provide police with info to curb money laundering: AG

FINANCE　•　The Latest News from the UK and Around the World | Sky News

Will she stand? Lagarde quits European Central Bank ahead of French election

FINANCE　•　The Latest News from the UK and Around the World | Sky News

Profits up billions at both UK's biggest mortgage provider and major oil producer